Latest News for: paroxysmal
Edit
Paroxysmal Nocturnal Hemoglobinuria Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, ...
GetNews 21 Aug 2025
DelveInsight’s, “Paroxysmal Nocturnal Haemoglobinuria Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Paroxysmal Nocturnal Haemoglobinuria pipeline landscape.
Edit
Paroxysmal Nocturnal Hemoglobinuria Treatment Market Set for Robust Growth Through 2034, Driven by Advancing Clinical ...
GetNews 11 Jul 2025
According to DelveInsight's estimates, the Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size in the 7MM was more than USD 1.3 billion in 2024, which is expected to increase by 2034 during the forecast period (2025–2034).
Edit
Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to ...
Nasdaq Globe Newswire 01 Jul 2025
The paroxysmal nocturnal hemoglobinuria market is witnessing robust growth, driven by increasing disease awareness, improved diagnostics, and the expanding adoption of targeted therapies.
- 1